Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...